Kane Biotech Inc.

Kane Biotech Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.04
Market Cap
CAD10.01 M
Shares Outstanding
80.11 M
Public Float
51.64 M

Profile

Address
196 Innovation Drive
Winnipeg Manitoba R3T 2N2
Canada
Employees -
Website http://www.kanebiotech.com
Updated 07/08/2019
Kane Biotech, Inc. is a biotechnology company, which engages in the development and commercialization of products to prevent and remove biofilms. It uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. Its trademarks include StrixNB, DispersinB, Aledex, blueste, AloSer, coactive, and Kane.

Financials

View All
Created with Highcharts 5.0.14Kane Biotech Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.1 4471 4471 6141 6141 7101 7102 5482 5482 7862 7863 2613 26120132014201520162017201801k2k3k4k
Created with Highcharts 5.0.14Kane Biotech Inc.Sales/Revenue. Fiscal year is January-December. All values CAD Thousands.15915941411041043793791 0351 035506506201320142015201620172018025050075010001250

Rashieda Gluck
Director
R. Philip Renaud
Chairman